Befektetés

FDA hits pause on Regenxbio gene therapies after child’s brain tumor; stock slumps
···

Az FDA felfüggeszti a Regenxbio génterápiáit egy gyermek agydaganata után; a részvények zuhannak

Rockville, Md., 2026. január 28., 10:02 (EST) Az amerikai Élelmiszer- és Gyógyszerügyi Hatóság klinikai szünetet rendelt el a Regenxbio kísérleti RGX-111 és RGX-121 génterápiáira, miután egy gyermeknél, aki kezelést kapott, agydaganatot találtak – jelentette be a vállalat szerdán. A Regenxbio részvényei mintegy
január 29, 2026

Technology News

  • DJI Lito rumors point to a lightweight drone for 2026, anchored by FCC filings
    February 3, 2026, 4:12 AM EST. DJI's next drone, nicknamed Lito, appears in regulatory paperwork rather than glossy promos. An FCC filing lists a model called Lito X1, but provides few technical details and no launch timeline. The public story hinges on speculation, optimism and a single image described as a drone leg, sparking debate over whether the device is a true lightweight quadcopter or a kitchen appliance with propellers. DJI has offered no press release, trailer or official specs to confirm the project. The FCC listing is the only official breadcrumb, shared by industry watchers as a sign that a small, portable drone could arrive in 2026. If real, the Lito would compete in a growing market for compact, easy-to-fly drones.